FDA 483 - ENDO USA, Inc. - October 18, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of PAR Sterile Products LLC in Rochester, MI, revealed significant deficiencies in their aseptic manufacturing processes and quality control systems. Observations included inadequate disinfectant efficacy studies, recurring HEPA filter failures without proper investigation, and a lack of accessible handwashing facilities. Additionally, the firm's environmental monitoring software was found to default to zero values, potentially masking actual contamination.
ID · bc42b7b8-b606-43d6-9f83-1afe317d5482